MedTrace Logo

A Mindfulness-based Intervention for Sexual Assault Survivors

NCT07515586 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-04-07

No results posted yet for this study

Summary

The goal is this pilot randomized trial is to learn if intervention 1 is feasible and acceptable. As a secondary goal, we aim to learn if intervention 1 reduces alcohol misuse and tobacco use in sexual assault survivors. The main questions it aims to answer are:

* Is intervention 1 feasible to implement?
* Is intervention 1 an acceptable intervention among the primary population, sexual assault survivors?
* Does intervention 1 reduce alcohol misuse and tobacco use?

Researchers will compare intervention 1 to an attention-placebo control group (e.g., online resources on healthy eating and nutrition).

Participants will:

* take online surveys at baseline, 1 month follow-up, and 3-month follow-up
* answer text-message questions at baseline and post-test
* view and engage in an educational program

Conditions

  • Alcohol Misuse
  • Tobacco Use
  • Mindfulness
  • Stress

Interventions

BEHAVIORAL

Intervention 1

A mindfulness-based intervention that aims to reduce alcohol misuse and tobacco use

BEHAVIORAL

comparison intervention

online resources on healthy eating and nutrition guidelines

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • Georgia State University

    lead OTHER

Principal Investigators

  • Anne Marie Schipani, PhD, MPH · Georgia State University School of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
24 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2027-10-31
Primary Completion
2029-03-31
Completion
2030-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07515586 on ClinicalTrials.gov